In August 2011, OBR made the first step towards the inter-campus network it is today by founding the Cambridge chapter. During the summer and throughout Michaelmas term, OBR-Cambridge hosted a popular seminar series with industry leaders from different sectors within biotech, helped launch the Roundtable Review, and successfully completed its first immersion project. The diverse membership reflects the multidisciplinary makeup of Europe’s largest biotech cluster, and currently consists of academics and industry professionals from across many sectors. We aim to build on the momentum of last term and continue to deliver insightful events, whilst greatly expanding within Cambridge and beyond. Please contact the chapter president Jonathan Brammeld for enquires regarding industry partnerships and joining the OBR-Cambridge team.
Cambridge Chapter Members
Jonathan is a PhD student at Cambridge and the Wellcome Trust Sanger Institute where his research focuses on acquired drug resistance to targeted therapies in cancer. Jonathan graduated from the University of Manchester with a BSc in Genetics and while Head of Events in Cambridge took considerable initiatives to establish an OBR chapter in Manchester. His interests lie in the biotechnology industry and consulting.
Nikola is a second year PhD student at the MRC Laboratory of Molecular Biology and his research is focused on the molecular mechanisms of WNT signal transduction and it’s deregulation in colon cancer. Previously Nikola was at the University of Belgrade, Serbia, where he graduated with a BSc and MSc degree in Molecular Biology and Physiology.
Daniel is a PhD candidate at the University of Cambridge and the MRC Laboratory of Molecular Biology, where he is working on GPCR biogenesis and the insertion mechanisms of integral membrane proteins. He finishedhis professional training in IT & multimedia production in Germany, received a BSc. in Biochemistry from the University of Technology in Munich andan MSc in Molecular Biophysics from the King's College London. During his time at the Yale School of Medicine as a BMEP fellow his research efforts focused on the cellular DNA damage response and the utilization of microRNA signatures as biomarkers in cancer. Daniel is interested in technology entrepreneurship and intellectual property.
Michael graduated from the University of Manchester in 2012 with a joint honours degree in Genetics and Japanese and the Faculty of Life Sciences Distinguished Achievement Award. He is currently a Research Assistant at the University of Colorado but will be starting a PhD at Cambridge in October 2013. When not tethered to a lab bench Michael can be found mountain climbing or biking.
Sophia is a first year PhD student at the Wellcome Trust Sanger Institute (Cambridge) and Public Health England (London). Last year, she graduated from Imperial College with a BSc in Biology. Her research is focused on the genetics and epidemiology of Legionella pneumophila, the bacterium that causes Legionnaires' disease. In addition to her research, Sophia is passionate about communicating science to the public. Her blog can be found at www.thetripletcode.com.
Joanne has held various senior scientific and business development positions related to the healthcare industry. She have a wealth of experience in sales and product development and specialize in 'bench to bedside' applications, specifically in tissue engineering, stem cell biology, and regenerative medicine. She has experience developing novel biomaterials/drug delivery/medical devices in association with in vitro and in vivo models and is passionate about teaching and research.
ConsultingInnovative Business Consulting
OBR-Consulting is a unique platform to meet the growing need for consultancy at the intersection of science, business and entrepreneurship.Learn more